Table 2.
Number of ovarian transplants showing functional, mature functional and murine blood vessels 3 days after transplantation
| Blood vessels | Control mice | VEGF 165 50 nM treated mice | p value |
|---|---|---|---|
| Dextran/FITC positive | 4/14 (28.6%) | 8/15 (53%) | 0.26 |
| Dextran/FITC and α-SMA Positive | 0/4 (0%) | 4/8 (50%) | 0.21 |
| CD31 positive | 3/14 (21.4%) | 6/15 (40%) | 0.43 |
Percentage of ovarian transplants showing functional blood vessels (dextran/FITC positive), mature functional blood vessels (double staining dextran/FITC and α-SMA positive) and murine blood vessels (CD31 positive) 3 days after transplantation in the VEGF165 treated group and control group.
Significance was established at a p value < 0.05.